Rosuvastatin, Sildenafil and Their Combination in Monocrotaline-Induced Pulmonary Hypertension in Rat

Acta Pharmaceutica - Croatia
doi 10.2478/acph-2014-0029
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Walter de Gruyter GmbH

Related search

Combination Use of Sildenafil and Simvastatin Increases BMPR-II Signal Transduction in Rats With Monocrotaline-Mediated Pulmonary Hypertension

Pulmonary Circulation
PulmonaryRespiratory Medicine
2011English

Rosuvastatin Intensifies the Beneficial Effects of Rho-Kinase Inhibitor in Reversal of Monocrotaline-Induced Pulmonary Hypertension

Archives of Medical Science
Medicine
2016English

Maprotiline Prevents Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

Frontiers in Pharmacology
Pharmacology
2018English

Effects of Inorganic Nitrate in a Rat Model of Monocrotaline‐induced Pulmonary Arterial Hypertension

Basic and Clinical Pharmacology and Toxicology
MedicineToxicologyPharmacology
2019English

Sildenafil Inhibits Hypoxia-Induced Pulmonary Hypertension

Circulation
Cardiovascular MedicinePhysiologyCardiology
2001English

Calorie Restriction Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2015English

Alteration of Pulmonary Artery Integrin Levels in Chronic Hypoxia and Monocrotaline-Induced Pulmonary Hypertension

Journal of Vascular Research
Cardiovascular MedicinePhysiologyCardiology
2011English

GPR143, a L-Dopa Receptor, Is Involved in Monocrotaline-Induced Pulmonary Hypertension in Rats

Proceedings for Annual Meeting of The Japanese Pharmacological Society
2020English

Interventions and Mechanisms of N‑acetylcysteine on Monocrotaline‑induced Pulmonary Arterial Hypertension

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy